diabetes
Bodywork: Getting the skinny on weight-loss drugs
A new weight-loss drug was recently approved. How is it different from the options on the market?
OMRF awarded $3.1 million to study diabetic heart disease
Work could lead to new treatments for heart disease
Bodywork: Getting the skinny on weight-loss drugs
I’ve heard a lot about a new generation of weight-loss drugs that have become quite popular. What are they, and how effective are they?
OMRF seeks volunteers for anti-aging study
The study will test whether a widely used diabetes drug can slow the aging process.
OMRF receives $2.2 million to study heart health
Two NIH grants will fund research into metabolic flexibility
